—Symposium Reviews— |
|
Pharmacologic Research for Bridging Drug Development and Treatment Strategy ∼Pharmacological Approach to Treatment by Clarification of Pathology∼ |
| ………M. Goda and Y. Yamamoto |
…485 |
|
Nitric Oxide Synthase-mediated Alteration of Intestinal P-glycoprotein under Hyperglycemic Stress |
| ………A. Nawa, W. Fujita-Hamabe, K. Nakamoto, and S. Tokuyama |
…487 |
|
Pharmaceutical Education for Psychotic Patients with Physical Complications |
| ………U. Iwakiri, J. Senba, K. Suenaga, and T. Shimazoe |
…493 |
|
Regulation of Dopaminergic Neuronal Activity by Heart-type Fatty Acid Binding Protein in the Brain |
| ………Y. Yamamoto, N. Shioda, Y. Owada, and K. Fukunaga |
…497 |
|
The Establishment of “Evidence Based Medicine” for the Treatment of Cerebral Stroke—Bridging Basic and Clinical Sciences— |
| ………S. Tokuyama and K. Fukunaga |
…503 |
|
Neurochemical Mechanisms of a Novel Alzheimer's Disease Therapeutics on Improvement of Cognition and Depressive Behavior |
| ………N. Shioda, Y. Yamamoto, F. Han, S. Moriguchi, and K. Fukunaga |
…505 |
|
Protective Effects of Cilostazol against Transient Focal Cerebral Ischemia and Hemorrhagic Transformation |
| ………M. Ishiguro and H. Hara |
…513 |
|
Is the GIRK Channel a Possible Target in the Development of a Novel Therapeutic Drug of Urinary Disturbance? |
| ………G. Yamamoto, F. Soeda, T. Shirasaki, and K. Takahama |
…523 |
|
Effectiveness of Metformin in Prevention of Development of Hyperglycemia and Neuronal Damage Caused by Ischemic Stress |
| ………W. Fujita-Hamabe, S. Harada, and S. Tokuyama |
…533 |
|
Neuro-glio-vascular Interaction in Ischemic Brains |
| ………M. Minami |
…539 |
—Reviews— |
|
Synthesis and Reaction of Hypervalent λ3-Iodane–Crown Ether Complexes |
| ………K. Miyamoto |
…545 |
|
Origins and Evolutionary Genomics of the Novel Swine-Origin Influenza A (H1N1) Virus in Humans —Past and Present Perspectives |
| ………M. M. A. Mamun and A. K. M. N. Huda |
…553 |
—Regular Articles— |
|
Effect of Pharmacists' Intervention on the Antibiotic Therapy for the Methicillin-resistant Staphylococcus aureus (MRSA) Infectious Diseases in the Intensive Care Unit |
| ………M. Imaura, Y. Kohata, K. Kobayashi, H. Takahashi, H. Yokoyama, T. Akase, and Y. Yamada |
…563 |
|
Pharmacoeconomic Evaluation of Hypothetical Over-the-counter Angiotensin-converting Enzyme (ACE) Inhibitors for the Prevention of Stroke in Patients with Grade I Hypertension |
| ………T. Uchikura, N. Yokoi, M. Hashiguchi, and M. Mochizuki |
…571 |
|
Effects of Ethanol Extracts of Herbal Medicines on Dermatitis in an Atopic Dermatitis Mouse Model |
| ………N. Takano, Y. Inokuchi, and M. Kurachi |
…581 |
|
Development of Skill Scale for Communication Skill Measurement of Pharmacist |
| ………H. Teramachi, N. Komada, K. Tanizawa, Y. Kuzuya, and T. Tsuchiya |
…587 |
|
Influence of Compression Pressure and Die-wall Pressure on Tablet Sticking |
| ………K. Kakimi, T. Niwa, and K. Danjo |
…597 |
|
New Drug Approvals over Three Decades from 1980 to 2009 in Japan—Their Therapeutic Targets and Biochemical Properties— |
| ………M. Muramatsu and Y. Arisue |
…603 |
|
Quality Assessment for Sustained Release Pharmaceutical Preparations by Dissolution Test Using Microdialysis-HPLC Method |
| ………N. Nagai, T. Murao, R. Inubuse, N. Konishi, and Y. Ito |
…621 |
—Note— |
|
Stability of Probucol-Polyvinylpyrrolidone Solid Dispersion Systems |
| ………Y. Kubo, N. Yagi, and H. Sekikawa |
…629 |
—Articles— |
|
Longer Working Hours of Pharmacists in the Ward Resulted in Lower Medication-related Errors—Survey of National University Hospitals in Japan |
| ………K. Matsubara, A. Toyama, H. Satoh, H. Suzuki, T. Awaya, Y. Tasaki, T. Yasuoka, and R. Horiuchi |
…635 |
|
Modeling of Autocatalytic Hydrolysis of Adefovir Dipivoxil in Solid Formulations |
| ………Y. Dong, Y. Zhang, B. Xiang, H. Deng, and J. Wu |
…643 |
|
Preparation of Simulation Programs regarding Excess-dose Drug Administration and Acute-phase Condition Changes and Its Evaluation by Students |
| ………J. Tokunaga, N. Takamura, K. Ogata, N. Setoguchi, T. Matsuoka, and K. Sato |
…655 |